Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial

• Ngā kaituhi matua: Rasha R. El-Kady (Author), Amani K. Ali (Author), Lamia M. El Wakeel (Author), Nagwa A. Sabri (Author), May A. Shawki (Author)
• Hōputu: Pukapuka
• I whakaputaina: SAGE Publishing, 2022-02-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Nicotinamide has been reported to protect against liver steatosis and metabolic imbalances in nonalcoholic fatty liver disease (NAFLD) in animal models. Objectives: The objective was to investigate the efficacy and safety of nicotinamide supplementation in diabetic NAFLD patients. Design...